Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kolapo M Oyebola"'
Autor:
Afolabi J Owoloye, Funmilayo C Ligali, Ojochenemi A Enejoh, Adesola Z Musa, Oluwagbemiga Aina, Emmanuel T Idowu, Kolapo M Oyebola
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0268269 (2022)
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires host glucose for survival and proliferation. On th
Externí odkaz:
https://doaj.org/article/0b4a51b4246a487abf867e351f52e684
Autor:
Kolapo M. Oyebola, Funmilayo C. Ligali, Afolabi J. Owoloye, Oluwagbemiga O. Aina, Yetunde M. Alo, Blessing Erinwusi, Michael J. Olufemi, Babatunde L. Salako
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background The burden of malaria persists in sub-Saharan Africa and the emergence of artemisinin resistance has introduced complexity to control efforts. Monitoring the efficacy of artemisinin-based treatment for malaria is crucial to addres
Externí odkaz:
https://doaj.org/article/a3b7a6b09d1d401fa9dca822ba9e5481
Autor:
Precious A. Akinnusi, Samuel O. Olubode, Ayomide O. Adebesin, Temidayo J. Osadipe, Daniel O. Nwankwo, Aanuoluwapo D. Adebisi, Bisi-Adeniyi Titilayo I, Yetunde M. Alo, Afolabi Owoloye, Kolapo M. Oyebola
Publikováno v:
Informatics in Medicine Unlocked, Vol 38, Iss , Pp 101206- (2023)
Resistance of malaria parasites to antimalarial drugs is a huge public health concern. Partial resistance of Plasmodium falciparum to artemisinin has been reported in many malaria-endemic regions. Therefore, there is a need to develop new and potent
Externí odkaz:
https://doaj.org/article/ff996a32fa2544ce8acba341c6630820
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background The devastating public health impact of malaria has prompted the need for effective interventions. Malaria control gained traction after the introduction of artemisinin-based combination therapy (ACT). However, the emergence of ar
Externí odkaz:
https://doaj.org/article/118424902a0b4d6d95dcc1d5bc867d44
Autor:
Olusola Ajibaye, Akinniyi A. Osuntoki, Emmanuel O. Balogun, Yetunde A. Olukosi, Bamidele A. Iwalokun, Kolapo M. Oyebola, Kenji Hikosaka, Yoh-ichi Watanabe, Godwin U. Ebiloma, Kiyoshi Kita, Alfred Amambua-Ngwa
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-12 (2020)
Abstract Background Vaccines are the most reliable alternative to elicit sterile immunity against malaria but their development has been hindered by polymorphisms and strain-specificity in previously studied antigens. New vaccine candidates are there
Externí odkaz:
https://doaj.org/article/7a83b4b6e3da4df8b060f7c7741432bf
Autor:
Florence A. Umunnakwe, Emmanuel T. Idowu, Olusola Ajibaye, Blessed Etoketim, Samuel Akindele, Aminat O. Shokunbi, Olubunmi A. Otubanjo, Gordon A. Awandare, Alfred Amambua-Ngwa, Kolapo M. Oyebola
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract Background Asymptomatic malaria parasites are significant sources of infections for onward malaria transmission. Conventional tools for malaria diagnosis such as microscopy and rapid diagnostic test kits (RDT) have relatively low sensitivity
Externí odkaz:
https://doaj.org/article/625a438528a7411c8a63b44ed1ddaffb
Nigeria at 62: Quagmire of malaria and the urgent need for deliberate and concerted control strategy
Publikováno v:
Frontiers in Tropical Diseases. 3
BackgroundSub-Saharan Africa (SSA) has disproportionately contributed the majority (95%) of all malaria cases and deaths for more than a decade (2010-2021) and Nigeria contributes the highest in global malaria cases and deaths in the last decade.Main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae08d58722906b5c163144932a25bab
Autor:
Afolabi J. Owoloye, Funmilayo C. Ligali, Ojochenemi A. Enejoh, Adesola Z. Musa, Oluwagbemiga Aina, Emmanuel T. Idowu, Kolapo M. Oyebola
Malaria chemotherapy has been plagued by parasite resistance. Novel drugs must be continually explored for malaria treatment. Plasmodium falciparum requires host glucose for survival and proliferation. Protein involved in hexose permeation, P. falcip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2593c6a733033a1e6c7cab51082037a
https://doi.org/10.1101/2022.04.27.489756
https://doi.org/10.1101/2022.04.27.489756
